Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fresenius Medical Care ( (FMS) ) has shared an announcement.
Fresenius Medical Care announced significant advancements in its Value-Based Care segment by investing EUR 312 million to increase its ownership in Interwell Health, a leader in renal value-based care. This strategic move is part of the company’s FME Reignite strategy, aimed at driving growth and innovation while reducing costs. Additionally, Tommy P. O’Connor has been appointed as the new CEO of Interwell Health, effective October 1, 2025, succeeding Robert Sepucha. O’Connor’s leadership is expected to enhance the integration and value creation within the segment, furthering Fresenius’ commitment to high-quality, cost-effective kidney care.
The most recent analyst rating on (FMS) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.
Spark’s Take on FMS Stock
According to Spark, TipRanks’ AI Analyst, FMS is a Outperform.
Fresenius Medical Care’s overall stock score reflects its stable financial performance and positive earnings call highlights, including strong revenue growth and a share buyback program. The technical analysis indicates a neutral trend, while the valuation is moderate with a decent dividend yield. Challenges such as reliance on debt and external cost pressures slightly temper the outlook.
To see Spark’s full report on FMS stock, click here.
More about Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, serving approximately 4.2 million patients globally who undergo dialysis treatment. The company operates a network of 3,676 dialysis clinics, providing treatments for around 300,000 patients worldwide, and is a leading supplier of dialysis products such as machines and dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange and the New York Stock Exchange.
Average Trading Volume: 323,656
Technical Sentiment Signal: Buy
Current Market Cap: $14.85B
See more insights into FMS stock on TipRanks’ Stock Analysis page.